Overview Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients Status: Terminated Trial end date: 2006-03-29 Target enrollment: Participant gender: Summary The purpose of this study is to demonstrate a long term efficacy of S18986 versus placebo on episodic memory performance in patients with MCI Phase: Phase 2 Details Lead Sponsor: Institut de Recherches Internationales Servier